Novel tricyclic BRD4 inhibitor for melanoma disclosed
Oct. 27, 2023
Protein bromodomain-containing protein 4 (BRD4) is involved in transcription, DNA replication and cell cycle among other processes, and its overexpression has been linked to several types of cancer and immune disorders.